Chemoinformaics analysis of cis,cis,cis-7,10,13-Hexadecatrienal
Molecular Weight | 234.383 | nRot | 11 |
Heavy Atom Molecular Weight | 208.175 | nRig | 4 |
Exact Molecular Weight | 234.198 | nRing | 0 |
Solubility: LogS | -3.246 | nHRing | 0 |
Solubility: LogP | 2.161 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 44.8586 |
nHD | 0 | BPOL | 26.9514 |
QED | 0.279 |
Synth | 2.891 |
Natural Product Likeliness | 1.742 |
NR-PPAR-gamma | 0.87 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.025 |
CACO-2 | -4.901 |
MDCK | 0.0000773 |
BBB | 0.193 |
PPB | 0.896285 |
VDSS | 2.959 |
FU | 0.0215051 |
CYP1A2-inh | 0.387 |
CYP1A2-sub | 0.876 |
CYP2c19-inh | 0.402 |
CYP2c19-sub | 0.197 |
CYP2c9-inh | 0.196 |
CYP2c9-sub | 0.92 |
CYP2d6-inh | 0.561 |
CYP2d6-sub | 0.934 |
CYP3a4-inh | 0.501 |
CYP3a4-sub | 0.138 |
CL | 4.786 |
T12 | 0.915 |
hERG | 0.093 |
Ames | 0.962 |
ROA | 0.005 |
SkinSen | 0.972 |
Carcinogencity | 0.748 |
EI | 0.967 |
Respiratory | 0.928 |
NR-Aromatase | 0.106 |
Antiviral | Yes |
Prediction | 0.777936 |